Sartorius, DE0007165631

Barclays raises Sartorius stock target to EUR 310.00

Published on 10/01/2026 at 11:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Barclays sets a EUR 310.00 target, up from EUR 300.00, on October 1, 2026. Sartorius stock costs EUR 257.00 versus EUR 259.15.

Fotorealistische Bioreaktor-Anlage in Reinraumhalle mit Edelstahltanks und Technikern
Sartorius AG (Vz.) DE0006292006 zeigt fotorealistisch eine sterile Bioreaktor-Anlage mit Technikern in weißer Reinraum-Schutzkleidung, Illustration mit AI erstellt.

Sartorius stock (ISIN DE0007165631) was trading at EUR 257.00 at Lang & Schwarz on October 1, 2026 at 11:00 a.m. CEST, minus 0.83 percent versus the EUR 259.15 prior close. According to Aktiencheck on October 1, 2026, Barclays raised its Sartorius price target from EUR 300.00 to EUR 310.00 and kept its Overweight rating. The change puts the upcoming quarterly report at the center of the investment case.

Target rises before third-quarter results

Barclays analyst Charles Pitman-King expects Sartorius to narrow its full-year outlook toward the midpoint of its existing range, according to Aktiencheck on October 1, 2026. The new target is EUR 10.00 above the former target, a 3.33 percent increase calculated against EUR 300.00.

The next reporting date is October 21, 2026, according to MarketScreener. That report will test whether the expected improvement in planning visibility is supported by operating figures rather than only by analyst valuation.

H1 growth has two speeds

In the first half of 2026, group sales revenue increased 7.70 percent on an operational basis in constant currencies, while underlying EBITDA rose 3.90 percent to EUR 548 million and the underlying EBITDA margin reached 30.30 percent, according to the Yahoo Finance transcript dated July 23, 2026.

Management confirmed full-year 2026 guidance for constant-currency sales growth of 5.00 percent to 9.00 percent and an underlying EBITDA margin above 30.00 percent. The contrast matters: recurring business growth exceeded 9.00 percent in the first half, while equipment growth was 2.00 percent, leaving the recovery dependent on both demand and project timing.

Stock remains below yearly high

The Lang & Schwarz price of EUR 257.00 is EUR 13.00 below the 52-week high of EUR 270.00 and EUR 58.50 above the 52-week low of EUR 198.50, with the market capitalization at EUR 17.8 billion as of October 1, 2026. The price therefore sits below the annual high even as Barclays lifts its valuation reference.

The further course of trading is shown by the continuously updated real-time quote of Sartorius stock.

Sartorius stock at a glance

  • Company: Sartorius AG
  • ISIN: DE0007165631
  • WKN: 716563
  • Ticker: SRT3
  • Primary exchange: Xetra
  • Price Lang & Schwarz (as of October 1, 2026, 11:00 a.m. CEST): EUR 257.00
  • Change versus prior close: minus 0.83 percent
  • Prior close Lang & Schwarz (September 30, 2026): EUR 259.15
  • Market capitalization: EUR 17.8 billion (as of October 1, 2026)
  • 52-week range: EUR 198.50-EUR 270.00 (as of October 1, 2026)
  • Sector / Industry: Healthcare / Medical Instruments and Supplies
  • Next earnings date: October 21, 2026

More news and analyses on Sartorius stock

Disclaimer...

en | DE0007165631 | SARTORIUS | boerse | 70209331 | bgmi